InvestorsHub Logo
Followers 2543
Posts 250734
Boards Moderated 34
Alias Born 05/06/2014

Re: None

Wednesday, 02/11/2015 7:45:42 PM

Wednesday, February 11, 2015 7:45:42 PM

Post# of 144813
$PMCB FOLKS (READ HERE: DD)....

Welcome to the PharmaCyte BioTech Inc. (PMCB)! BEFORE getting into the below I'd like to direct your attention to the Intro Page (aka iBox), which can be found at the top of the page on the right hand corner. Make sure it says, "SHOW INTRO" I encourage EVERYONE to visit the iBox (and to SHARE this with new folks), so others can find "some" easier DD.

http://investorshub.advfn.com/PharmaCyte-Biotech-Inc-PMCB-5034/

1. FDA Grants Orphan Drug Designation to Nuvilex for Pancreatic Cancer Treatment
Read more at: http://globenewswire.com/news-release/2014/12/22/693421/10113176/en/FDA-Grants-Orphan-Drug-Designation-to-Nuvilex-for-Pancreatic-Cancer-Treatment.html#sthash.S59r45U0.dpuf

2. PharmaCyte Biotech Analyst Report Issued by BrokerBank Securities, Inc.
Read more at: http://www.prnewswire.com/news-releases/pharmacyte-biotech-analyst-report-issued-by-brokerbank-securities-inc-300033999.html

3. PharmaCyte Biotech's International Diabetes Consortium Sets Path Forward to Develop Novel Treatment for Diabetes
Read more at: http://globenewswire.com/news-release/2015/02/10/704889/10119399/en/PharmaCyte-Biotech-s-International-Diabetes-Consortium-Sets-Path-Forward-to-Develop-Novel-Treatment-for-Diabetes.html#sthash.a500SFqx.dpuf

4.PharmaCyte Biotech's Pancreatic Cancer Treatment Named as Near-Term Approach to Rising Pancreatic Cancer Rates
Read more at: http://globenewswire.com/news-release/2015/01/15/697687/10115663/en/PharmaCyte-Biotech-s-Pancreatic-Cancer-Treatment-Named-as-Near-Term-Approach-to-Rising-Pancreatic-Cancer-Rates.html#sthash.fiztoExn.dpuf

5. PharmaCyte Biotech's Expanded Follow-up Study on Malignant Ascites Fluid Accumulation in Final Stages of Preparation
Read more at: http://www.nasdaq.com/press-release/pharmacyte-biotechs-expanded-followup-study-on-malignant-ascites-fluid-accumulation-in-final-stage-20150126-00537#ixzz3Py5xyHCy

6. New Approaches Tackle Rising Pancreatic Cancer Rates
Read more at: http://jnci.oxfordjournals.org/content/106/12/dju417.full

Blessing and Love!

Go $PMCB

Pistol Pete!

"Patience, persistence and perspiration make an unbeatable combination for success."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News